Scientists have long known that the Epstein-Barr virus (EBV), a very common virus best known for causing mono, is strongly linked to multiple sclerosis. Now, new research from Sweden offers…
Read More
Researchers are continuing to explore new treatment options for multiple sclerosis, especially for progressive forms of the disease where effective therapies remain limited. One promising area of research involves BTK…
Recent changes to federal tax law may affect how your charitable gifts are treated starting in the 2026 tax year. Understanding these updates can help you make informed decisions and…
From new treatment targets and trial designs to broader inclusion and predictive biomarkers, MS research is entering a new era focused on progression, precision, and quality of life. For…
We are deeply saddened to share the news of the passing of our colleague and friend, Patricia Daily. Many in our community knew Pat, worked alongside her, or benefited from…
A research emphasis on measuring relapses and tracking MRIs naturally leads to a treatment emphasis on preventing relapses and reducing MRI activity. And of course, both are still important. But…
One encouraging thread across recent studies is how daily habits can build cognitive reserve — the brain’s ability to work around damage — while also improving mood, sleep, and physical…
One of the most common topics that comes up in RMMSC education programs and Q&A sessions is the question of discontinuing disease-modifying therapies (DMTs). Patients want to know when they…
For this issue of InforMS, we sat down with David Dombeck, a research participant at the Rocky Mountain MS Center at the University of Colorado. David was diagnosed later in…
Meaningful progress in multiple sclerosis research often begins with a single question. But those questions may not always fit the requirements of large federal or medical industry grants. Research that…
